Stock Price
1,904.00
Daily Change
25.80 1.37%
Monthly
14.11%
Yearly
10.05%
Q2 Forecast
1,838.01

Sun Pharmaceuticals reported INR113.32B in Cash and Equivalent for its fiscal quarter ending in March of 2025.





Cash And Equivalent Change Date
Aspen Pharmacare ZAR 5.62B 789M Dec/2025
Bharat Petroleum INR 137.44B 131.86B Sep/2025
Cipla INR 7.96B 39.9M Sep/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Jiangsu Hengrui CNY 40.96B 591.41M Dec/2025
Sh Fosun Pharma CNY 13.1B 1.63B Dec/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
UPL INR 41.52B 53.85B Sep/2025